Furthermore, the emerging data indicate that combining PD-L1 inhibitors with other therapies including chemotherapy, radiotherapy and immunotherapy might be more beneficial to cure cancer patients [26–28] and we already have been studied that ionizing radiation was efficient modality to trigger NK cell-mediated immune responses [29]. The gene discussed is CD274; the disease is cancer.